Leider Harry L. 4
4 · Organicell Regenerative Medicine, Inc. · Filed Dec 20, 2023
Insider Transaction Report
Form 4
Leider Harry L.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2023-12-19$1.31/sh−5,248$6,901→ 0 total(indirect: See footnote)
Footnotes (1)
- [F1]The shares disposed of were held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.